Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Sander

Showing results (21-30 of 206) with videos related to

Pageof 21
Sort By:
International Journal of Clinical Practice|October 8, 2003
Levetiracetam: a new therapeutic option for refractory epilepsyA Pinto, J W Sander
European Neurology|October 16, 1999
Classification of the epilepsies: time for a change? A critical review of the International Classification of the Epilepsies and Epileptic Syndromes (ICEES) and its usefulness in clinical practice and epidemiological studies of epilepsyA D Everitt, J W Sander
Lancet (London, England)|May 20, 1995
Lamotrigine versus carbamazepine in epilepsyM F O'Donoghue, J W Sander
Seizure|September 1, 1996
Topiramate: a new antiepileptic drug for refractory epilepsyM C Walker, J W Sander
British Journal of Hospital Medicine|August 1, 1990
Petit mal statusJ W Sander, Y M Hart
Neurology|November 1, 1991
Vigabatrin treatment of epilepsyJ W Sander, S D Shorvon
Neurology|September 1, 1996
Fluoxetine and seizuresM C Walker, J W Sander
Epilepsy Research|October 1, 1992
An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapyJ W Sander, P N Patsalos
Drug Safety|July 1, 1994
Newer antiepileptic drugs. Towards an improved risk-benefit ratioP N Patsalos, J W Sander
Annals of Neurology|June 1, 1986
Tropical spastic paraparesisR J Coleman, J W Sander
Pageof 21

Showing results (21-30 of 206) with videos related to

Sort By:
Pageof 21
International Journal of Clinical Practice|October 8, 2003
Levetiracetam: a new therapeutic option for refractory epilepsyA Pinto, J W Sander
European Neurology|October 16, 1999
Classification of the epilepsies: time for a change? A critical review of the International Classification of the Epilepsies and Epileptic Syndromes (ICEES) and its usefulness in clinical practice and epidemiological studies of epilepsyA D Everitt, J W Sander
Lancet (London, England)|May 20, 1995
Lamotrigine versus carbamazepine in epilepsyM F O'Donoghue, J W Sander
Seizure|September 1, 1996
Topiramate: a new antiepileptic drug for refractory epilepsyM C Walker, J W Sander
British Journal of Hospital Medicine|August 1, 1990
Petit mal statusJ W Sander, Y M Hart
Neurology|November 1, 1991
Vigabatrin treatment of epilepsyJ W Sander, S D Shorvon
Neurology|September 1, 1996
Fluoxetine and seizuresM C Walker, J W Sander
Epilepsy Research|October 1, 1992
An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapyJ W Sander, P N Patsalos
Drug Safety|July 1, 1994
Newer antiepileptic drugs. Towards an improved risk-benefit ratioP N Patsalos, J W Sander
Annals of Neurology|June 1, 1986
Tropical spastic paraparesisR J Coleman, J W Sander
Pageof 21